Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Journal of Adolescent and Young Adult Oncology
|
September 11, 2020
Novel Genomic Differences in Cell-Free Circulating DNA Profiles of Young- Versus Older-Onset Colorectal Cancer
Afsaneh Barzi, Caroline M Weipert, Carin R Espenschied, et al.
Molecular Diagnosis & Therapy
|
January 29, 2013
Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions
April D Sorrell, Carin R Espenschied, Julie O Culver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2017
Multigene Panel Testing Provides a New Perspective on Lynch Syndrome
Carin R Espenschied, Holly LaDuca, Shuwei Li, et al.
JCO Precision Oncology
|
May 5, 2025
Assessment of Circulating Tumor DNA Burden in Patients With Metastatic Gastric Cancer Using Real-World Data
Senaka A Peter, Razvan Cristescu, Carol Peña, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2012
Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results
Laura C Beamer, Marcia L Grant, Carin R Espenschied, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
May 22, 2012
Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs
Carin R Espenschied, Deborah J MacDonald, Julie O Culver, et al.
Frontiers in Oncology
|
February 26, 2024
<i>ERBB2</i> (HER2) amplifications and co-occurring <i>KRAS</i> alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition
Afsaneh Barzi, Caroline M Weipert, Carin R Espenschied, et al.
The Journal of Liquid Biopsy
|
November 24, 2025
Chemotherapy response monitoring with DNA methylation-based ctDNA tumor fraction: Evidence from a real-world cohort of patients with advanced common solid malignancies
Christian D Rolfo, Moh'd M Khushman, Alessandro Russo, et al.
Clinical Lung Cancer
|
July 16, 2020
Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis
Karen L Reckamp, Tejas Patil, Kedar Kirtane, et al.
Cancer Genetics
|
May 21, 2018
Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent
Zöe Powis, Carin R Espenschied, Holly LaDuca, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Journal of Adolescent and Young Adult Oncology
|
September 11, 2020
Novel Genomic Differences in Cell-Free Circulating DNA Profiles of Young- Versus Older-Onset Colorectal Cancer
Afsaneh Barzi, Caroline M Weipert, Carin R Espenschied, et al.
Molecular Diagnosis & Therapy
|
January 29, 2013
Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions
April D Sorrell, Carin R Espenschied, Julie O Culver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2017
Multigene Panel Testing Provides a New Perspective on Lynch Syndrome
Carin R Espenschied, Holly LaDuca, Shuwei Li, et al.
JCO Precision Oncology
|
May 5, 2025
Assessment of Circulating Tumor DNA Burden in Patients With Metastatic Gastric Cancer Using Real-World Data
Senaka A Peter, Razvan Cristescu, Carol Peña, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2012
Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results
Laura C Beamer, Marcia L Grant, Carin R Espenschied, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
May 22, 2012
Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs
Carin R Espenschied, Deborah J MacDonald, Julie O Culver, et al.
Frontiers in Oncology
|
February 26, 2024
<i>ERBB2</i> (HER2) amplifications and co-occurring <i>KRAS</i> alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition
Afsaneh Barzi, Caroline M Weipert, Carin R Espenschied, et al.
The Journal of Liquid Biopsy
|
November 24, 2025
Chemotherapy response monitoring with DNA methylation-based ctDNA tumor fraction: Evidence from a real-world cohort of patients with advanced common solid malignancies
Christian D Rolfo, Moh'd M Khushman, Alessandro Russo, et al.
Clinical Lung Cancer
|
July 16, 2020
Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis
Karen L Reckamp, Tejas Patil, Kedar Kirtane, et al.
Cancer Genetics
|
May 21, 2018
Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent
Zöe Powis, Carin R Espenschied, Holly LaDuca, et al.
Page
of 3